Daniel L. Hamilos

16.3k total citations · 3 hit papers
96 papers, 6.8k citations indexed

About

Daniel L. Hamilos is a scholar working on Otorhinolaryngology, Immunology and Allergy and Physiology. According to data from OpenAlex, Daniel L. Hamilos has authored 96 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Otorhinolaryngology, 36 papers in Immunology and Allergy and 35 papers in Physiology. Recurrent topics in Daniel L. Hamilos's work include Sinusitis and nasal conditions (45 papers), Allergic Rhinitis and Sensitization (35 papers) and Asthma and respiratory diseases (35 papers). Daniel L. Hamilos is often cited by papers focused on Sinusitis and nasal conditions (45 papers), Allergic Rhinitis and Sensitization (35 papers) and Asthma and respiratory diseases (35 papers). Daniel L. Hamilos collaborates with scholars based in United States, Spain and Belgium. Daniel L. Hamilos's co-authors include Mark S. Dykewicz, Qutayba Hamid, Eli O. Meltzer, Bradley F. Marple, H. James Wedner, David W. Kennedy, Raymond P. Wood, Michael R. Jacobs, Jack B. Anon and James A. Stankiewicz and has published in prestigious journals such as Annals of Internal Medicine, Nature Immunology and The Journal of Immunology.

In The Last Decade

Daniel L. Hamilos

93 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adult Chronic Rhinosinusitis: Definitions, Diagnosis, Epidemiology, and Pathophysiology

2003 764 citations Daniel L. Hamilos, David W. Kennedy et al. profile →
Clinical practice guideline: Adult sinusitis

2007 719 citations Daniel L. Hamilos et al. profile →
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy

2011 429 citations Daniel L. Hamilos et al. profile →

Peers

Countries citing papers authored by Daniel L. Hamilos

Since Specialization

Citations

This map shows the geographic impact of Daniel L. Hamilos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Hamilos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Hamilos more than expected).

Fields of papers citing papers by Daniel L. Hamilos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Hamilos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Hamilos. The network helps show where Daniel L. Hamilos may publish in the future.

Co-authorship network of co-authors of Daniel L. Hamilos

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Hamilos. A scholar is included among the top collaborators of Daniel L. Hamilos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Hamilos. Daniel L. Hamilos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung 2020 ·Nature Immunology ·Lucas Faustino, Jason W. Griffith, Rod A. Rahimi, (unknown), Daniel L. Hamilos, (unknown), Benjamin D. Medoff, James J. Moon, Dario A.A. Vignali, Andrew D. Luster	76
2	Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis 2019 ·Allergy ·Claus Bachert, Peter W. Hellings, Joaquim Mullol, Daniel L. Hamilos, Philippe Gevaert, Robert M. Naclerio, Vijay N. Joish, Jingdong Chao, Leda Mannent, Nikhil Amin, Adeline Abbé, (unknown), Chunpeng Fan, Gianluca Pirozzi, Neil M.H. Graham, Puneet Mahajan, Heribert Staudinger, Asif Khan	74
3	Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP 2019 ·Rhinology Journal ·Claus Bachert, S. James Zinreich, Peter W. Hellings, Joaquim Mullol, Daniel L. Hamilos, Philippe Gevaert, Robert M. Naclerio, Nikhil Amin, (unknown), Chunpeng Fan, Donghui Zhang, Heribert Staudinger, Gianluca Pirozzi, Neil M.H. Graham, Asif Khan, Leda Mannent	35
4	Automated segmentation and quantification of airway mucus with endobronchial optical coherence tomography 2017 ·Biomedical Optics Express ·David C. Adams, Hamid Pahlevaninezhad, Margit V. Szabari, (unknown), Daniel L. Hamilos, Mehmet Kesımer, Richard C. Boucher, Andrew D. Luster, Benjamin D. Medoff, Melissa J. Suter	14
5	Allergic asthma is distinguished by sensitivity of allergen-specific CD4 ⁺ T cells and airway structural cells to type 2 inflammation 2016 ·Science Translational Medicine ·(unknown), Morris Ling, David C. Adams, Lucas Faustino, Sabina A. Islam, Roshi Afshar, Jason W. Griffith, R. Scott Harris, Aylwin Ng, Giorgia Radicioni, Amina A. Ford, (unknown), Ramnik J. Xavier, William W. Kwok, Richard C. Boucher, James Moon, Daniel L. Hamilos, Mehmet Kesımer, Melissa J. Suter, Benjamin D. Medoff, Andrew D. Luster	46
6	Chronic Rhinosinusitis in Patients with Cystic Fibrosis 2016 ·The Journal of Allergy and Clinical Immunology In Practice ·Daniel L. Hamilos	38
7	¹⁸F-FDG Uptake Rate Is a Biomarker of Eosinophilic Inflammation and Airway Response in Asthma 2011 ·Journal of Nuclear Medicine ·R. Scott Harris, José G. Venegas, (unknown), Tilo Winkler, (unknown), Guido Musch, Marcos F. Vidal Melo, Nicolas de Prost, Daniel L. Hamilos, Roshi Afshar, (unknown), Andrew D. Luster, Benjamin D. Medoff	45
8	Rhinitis and sinusitis 2010 ·Journal of Allergy and Clinical Immunology ·Mark S. Dykewicz, Daniel L. Hamilos	320
9	Nasal and sinus endoscopy for medical management of resistant rhinosinusitis, including postsurgical patients 2007 ·Journal of Allergy and Clinical Immunology ·(unknown), Allen Adinoff, Brian A. Smart, Daniel L. Hamilos	23
10	Membrane‐bound eotaxin‐3 mediates eosinophil transepithelial migration in IL‐4‐stimulated epithelial cells 2006 ·European Journal of Immunology ·Qian Yuan, Gabriele Campanella, Richard A. Colvin, Daniel L. Hamilos, (unknown), Anuja Mathew, Terry K. Means, Andrew D. Luster	35
11	Treatment of Chronic Rhinosinusitis with High-Dose Oral Terbinafine: A Double Blind, Placebo-Controlled Study 2005 ·The Laryngoscope ·David W. Kennedy, F KUHN, Daniel L. Hamilos, S. James Zinreich, (unknown), Ghulam Warsi, Pascal Pfister, Amir Tavakkol	81
12	Asthma Exacerbations after Glucocorticoid Withdrawal Reflects T Cell Recruitment to the Airway 2004 ·American Journal of Respiratory and Critical Care Medicine ·Mario Castro, Sharon Bloch, (unknown), (unknown), Daniel L. Hamilos, (unknown), (unknown), (unknown), Joseph Bradley, Kenneth B. Schechtman, Michael J. Holtzman	40
13	Bloody diarrhea, fever, and pancytopenia in a patient with active ulcerative colitis 2003 ·Annals of Allergy Asthma & Immunology ·(unknown), Daniel L. Hamilos	2
14	Reply 2002 ·Journal of Allergy and Clinical Immunology ·Daniel L. Hamilos	0
15	Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease 1999 ·Journal of Allergy and Clinical Immunology ·Daniel L. Hamilos, Stanley E. Thawley, Maggie A. Kramper, (unknown), Qutayba Hamid	70
16	Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis 1995 ·Journal of Allergy and Clinical Immunology ·Daniel L. Hamilos, D LEUNG, Raymond P. Wood, Lea Cunningham, (unknown), Z Yasruel, E Schotman, Qutayba Hamid	266
17	Suggested approaches for research protocols involving the potential for life-threatening reactions 1993 ·Journal of Allergy and Clinical Immunology ·Daniel L. Hamilos, John Oppenheimer, (unknown), Sally Wenzel, (unknown), Richard F. Lockey, David B.K. Golden, Leland L. Fan, (unknown), Stefan Böck, John W. Yunginger, Donald Stevenson, Timothy J. Sullivan, Thomas Corbridge	14
18	Chronic hyperplastic sinusitis: Association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 1993 ·Journal of Allergy and Clinical Immunology ·Daniel L. Hamilos, D LEUNG, Raymond P. Wood, A M Meyers, (unknown), J Barkans, Q. Meng, Lynn Cunningham, (unknown), A. B. Kay, Qutayba Hamid	135
19	Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin 1991 ·Journal of Allergy and Clinical Immunology ·Daniel L. Hamilos, (unknown)	40
20	Antigen presenting cells 1989 ·Immunologic Research ·Daniel L. Hamilos	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact